OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Blood Potassium Abnormal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,624 reports · 99 co-occurring drugs

As of the last recalculation, Blood Potassium Abnormal appears in 2,624 FAERS reports alongside 99 co-occurring drug terms. The strongest observed disproportionality signal is PATIROMER (PRR 47.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Patiromer8147.948.1
Ado-Trastuzumab Emtansine1514.214.2
Travoprost1412.912.9
Teduglutide2112.512.5
Eplerenone1911.811.9
Paricalcitol1910.710.8
Metolazone139.29.2
Voclosporin109.29.2
Bumetanide298.88.8
Dextrose148.58.5
Dextrose Monohydrate148.38.4
Sacubitril And Valsartan1168.28.3
Chlorthalidone128.28.2
Octreotide Acetate307.87.9
Torsemide327.77.8
Diphenoxylate Hydrochloride And Atropine Sulfate137.67.6
Nebivolol157.57.5
Potassium Chloride Extended-Release817.17.1
Ribociclib287.17.1
Dexamethasone Sodium Phosphate97.07.1
Potassium Chloride, Dextrose Monohydrate807.07.0
Potassium Chloride Oral807.07.0
Potassium Chloride946.86.8
Spironolactone1136.66.6
Sodium Bicarbonate196.56.5
Sodium Bicarbonate Injection,196.56.5
Psyllium Husk86.46.4
Amiodarone Hydrochloride96.46.4
Calcitriol Capsules 0.25 Mcg166.46.4
Calcitriol Capsules 0.5 Mcg166.46.4
Calcitriol166.36.3
Doxepin86.36.3
Butalbital, Acetaminophen, And Caffeine86.06.0
Selexipag195.95.9
Abiraterone105.85.8
Insulin Human285.65.6
Salmeterol Xinafoate65.55.5
Nebivolol Hydrochloride235.45.4
Dofetilide75.35.3
Agalsidase Beta65.25.2
Posaconazole Delayed-Release75.15.1
Inclisiran55.05.0
Doxazosin174.84.8
Asfotase Alfa64.84.8
Febuxostat104.74.7
Carvedilol794.74.7
Ezetimibe And Simvastatin94.74.7
Febuxostat Tablets 40 Mg64.74.7
Febuxostat Tablets 80 Mg64.74.7
Valsartan And Hydrochlorothiazide84.74.7
Dronedarone64.74.7
Avapritinib74.64.6
Desoximetasone114.64.6
Tolvaptan84.44.4
Amlodipine Besylate And Valsartan64.34.3
Epoprostenol74.34.3
Venetoclax303.93.9
Lenvatinib163.93.9
Macitentan333.83.8
Ambrisentan583.73.7
Velpatasvir And Sofosbuvir63.73.7
Trifluridine And Tipiracil53.73.7
Riociguat153.73.7
Cabozantinib223.73.7
Treprostinil543.53.5
Doxorubicin Hydrochloride143.43.4
Interferon Beta-1B83.33.3
Acalabrutinib53.33.3
Ibrutinib333.33.3
Bosentan203.23.2
Brimonidine Tartrate73.13.1
Abiraterone Acetate163.13.1
Eculizumab213.13.1
Azacitidine For73.13.1
Nintedanib123.03.0
Ruxolitinib273.03.0
Pembrolizumab393.03.0
Romosozumab-Aqqg52.92.9
Sevoflurane32.92.9
Sevelamer Carbonate42.82.8
Alpelisib32.72.7
Rucaparib32.72.7
Rimegepant Sulfate42.52.5
Peginterferon Beta-1A42.42.4
Azacitidine92.42.4
Fam-Trastuzumab Deruxtecan-Nxki32.42.4
Lenalidomide1212.32.3
Cetuximab92.32.3
Droxidopa62.22.2
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride82.02.0
Tafamidis32.02.0
Diroximel Fumarate32.02.0
Abemaciclib52.02.0
Durvalumab52.02.0
Lifitegrast41.91.9
Relugolix51.71.7
Pomalidomide191.51.5
Cinacalcet Hydrochloride81.41.4
Pimavanserin Tartrate60.90.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.